A detailed history of Td Asset Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Td Asset Management Inc holds 44,158 shares of RGEN stock, worth $6.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,158
Previous 58,965 25.11%
Holding current value
$6.45 Million
Previous $7.43 Million 11.6%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$119.79 - $167.35 $1.77 Million - $2.48 Million
-14,807 Reduced 25.11%
44,158 $6.57 Million
Q2 2024

Aug 02, 2024

BUY
$120.0 - $182.95 $147,960 - $225,577
1,233 Added 2.14%
58,965 $7.43 Million
Q1 2024

May 08, 2024

SELL
$170.78 - $208.42 $666,042 - $812,838
-3,900 Reduced 6.33%
57,732 $10.6 Million
Q4 2023

Feb 12, 2024

BUY
$114.17 - $185.35 $275,492 - $447,249
2,413 Added 4.07%
61,632 $11.1 Million
Q3 2023

Oct 27, 2023

BUY
$138.78 - $176.51 $3.71 Million - $4.72 Million
26,754 Added 82.41%
59,219 $9.42 Million
Q2 2023

Aug 09, 2023

BUY
$138.42 - $180.31 $944,716 - $1.23 Million
6,825 Added 26.62%
32,465 $4.59 Million
Q1 2023

May 10, 2023

BUY
$154.26 - $198.1 $449,050 - $576,669
2,911 Added 12.81%
25,640 $4.32 Million
Q4 2022

Feb 06, 2023

BUY
$162.42 - $220.56 $537,610 - $730,053
3,310 Added 17.05%
22,729 $3.85 Million
Q3 2022

Nov 07, 2022

BUY
$160.42 - $256.21 $402,654 - $643,087
2,510 Added 14.84%
19,419 $3.71 Million
Q1 2022

May 10, 2022

BUY
$161.19 - $257.96 $693,600 - $1.11 Million
4,303 Added 34.13%
16,909 $3.18 Million
Q4 2021

Feb 10, 2022

BUY
$247.59 - $304.47 $148,554 - $182,682
600 Added 5.0%
12,606 $3.34 Million
Q3 2021

Nov 09, 2021

BUY
$194.77 - $324.21 $447,971 - $745,683
2,300 Added 23.7%
12,006 $3.47 Million
Q2 2021

Aug 11, 2021

BUY
$165.87 - $220.95 $516,021 - $687,375
3,111 Added 47.17%
9,706 $2.39 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $238,268 - $298,889
1,321 Added 25.05%
6,595 $1.28 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $177,696 - $247,884
1,200 Added 29.46%
5,274 $1.01 Million
Q2 2020

Aug 13, 2020

BUY
$94.33 - $140.48 $18,866 - $28,095
200 Added 5.16%
4,074 $504,000
Q1 2020

May 15, 2020

BUY
$84.96 - $109.14 $329,135 - $422,808
3,874 New
3,874 $374,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.11B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.